Smith & Nephew (SNNUF) Interest & Investment Income (2025)
Smith & Nephew (SNNUF) reported Interest & Investment Income of $28.0 million for Q4 2025.
Smith & Nephew (SNNUF) Interest & Investment Income (2025) Analysis & Trends
Smith & Nephew has reported Interest & Investment Income for 1 years, with the latest figure at $28.0 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income changed N/A year-over-year to $28.0 million; the trailing twelve-month figure through Dec 2025 stood at $28.0 million (changed N/A YoY), and the FY2025 full-year result was $28.0 million, up 16.67% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $28.0 million.
- The five-year high for Interest & Investment Income was $28.0 million in Q4 2025, with the low at $28.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 40.98 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Smith & Nephew | - | - | - | 28.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.00 Mn |